Microbiota in animals provides an important barrier to infection against diverse microbial pathogens and encode an important reservoir of anti-infective and protective factors. To identify anti-infective and protective factors from beneficial bacterial species in gut microbiota, we used C. elegans as a model organism to evaluate individual bacteria species and specific factors for protective activity against human enteric pathogens such as Salmonella typhimurium. We discovered that a unique secreted peptidoglycan hydrolase, SagA, from Enteroccocus faecium (commensal bacteria in humans and other animals) enhanced epithelial barrier function and was sufficient to protect C. elegans and mice from S. typhimurium pathogenesis. These exciting results suggest that SagA has unique activity in vivo and may be used to improve host barrier function to protect against enteric pathogens and inflammatory bowl diseases (IBDs) in humans. To harness the protective activity of SagA for therapeutic use, we propose to determine the precise mechanism(s) of SagA-mediated protection in mammalian cells and mouse models. Our discovery of SagA protective activity provides an exciting opportunity to understand the protective mechanism of beneficial gut bacterial species such as E. faecium and to prevent or treat enteric microbial infections as well as inflammatory bowl disorders.

Public Health Relevance

Gut microbiota can enhance host resistance enteric pathogens, but their mechanisms of actions have been not fully elucidated. Using C. elegans as an animal model to commensal bacteria mechanisms, we discovered a novel secreted protein that enhances host epithelial barrier integrity and pathogen resistance. To harness the protective activity of this secreted probiotic factor for therapeutic applications, we will determine its mechanism of action on mammalian intestinal epithelial cells ex vivo and in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM103593-08
Application #
9856888
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Zhao, Xiaoli
Project Start
2013-01-01
Project End
2021-01-31
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
8
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Biology
Type
Graduate Schools
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Rangan, Kavita J; Hang, Howard C (2017) Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria. Trends Biochem Sci 42:887-898
Rangan, Kavita J; Pedicord, Virginia A; Wang, Yen-Chih et al. (2016) A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens. Science 353:1434-1437
Pedicord, Virginia A; Lockhart, Ainsley A K; Rangan, Kavita J et al. (2016) Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance. Sci Immunol 1: